Year: 2008
Type: article
Abstract: Adrenal insufficiencyAdrenal insufficiency (AI) is either of primary origin, mostly due to autoimmunemediated destruction of the adrenal gland, or of secondary origin, in most cases caused by tumours located in the hypothalamic-pituitary region affecting the regulatory control of adrenal cortisol release Common clinical symptoms of AI (fatigue, nausea, weight loss and myalgia) are rather non-specific and may lead to considerable delay in diagnosis.Acute AI is life-threatening and may present with fever, severe hypotension or hypovolaemic shock, abdominal tension and, in some cases, even coma Diagnostic tests should never delay treatment in cases of suspected acute AI.The short synacthen test is the most suitable tool for establishing the diagnosis of AI; baseline cortisol is of limited value Therapeutic management of AI always requires cortisol replacement.Monitoring is based on clinical judgment.Mineralocorticoid replacement can be monitored by supine and erect blood pressure, urea and electrolytes, and plasma renin activity.Dehydroepiandrosterone (DHEA) replacement therapy can be a beneficial option, in particular in women with signs of androgen deficiency due to lack of adrenal DHEA production Recent data indicate significantly impaired well-being, increased rates of disablement, inability to work and mortality.Optimisation of therapeutic strategies in AI are therefore an important target of future research
Source: Clinical Medicine
Author: Wiebke Arlt
Institution: University of Birmingham
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,500
OpenAlex ID: W4233088561
